As mental health challenges grow more complex and costly, new solutions are essential. What if one of the most powerful answers isn’t a new drug, but food? What if we’ve been missing an overlooked root cause of and a treatment approach to psychiatric suffering that science is now beginning to confirm?

ACCORD is proud to announce that the Baszucki Group has awarded more than $600,000 in research funding to support a groundbreaking study on metabolic psychiatry in partnership with McLean Hospital. This three-year project, led by Dr. Virginie-Anne Chouinard and Dr. Matthew Bernstein, along with a dedicated research assistant and biostatistician, will explore how ketogenic and other metabolic interventions influence psychiatric symptoms, metabolic health and overall functioning.